Skip to Main Content

Paper Details

Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort.
Cancer Epidemiol Biomarkers Prev
2
2023
Cholesterol, Colorectal Cancer, Dyslipidemia, HDL-C, LDL cholesterol, LDL-C, Triglyceride, cholesterol, colorectal cancer, dyslipidemia, high- and low-density lipoprotein cholesterol, metabolic syndrome, participants, triglyceride

Datasets

Release 1.2